Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ Key Concepts ++ Epidemiology Six to ten percent of patients develop cardiogenic shock after myocardial infarction. Mitral regurgitation (MR) occurs in 8 to 50 percent of patients after myocardial infarction. Post-infarct ventricular septal defects (VSD) occurs in <0.5 percent of myocardial infarction (MI) patients. Only 24 percent of medically treated patients with post-infarct VSD survive 30 days. In autopsy series, 30 percent of myocardial infarction (MI) is accompanied by ventricular free wall rupture (VFWR). The incidence of left ventricular aneurysms depends on exact definition; 10 to 35 percent of patients will develop region of systolic akinesia or dyskinesia after transmural myocardial infarction (MI). Pathophysiology In cardiogenic shock associated with MI, worsening ventricular function leads to decreased coronary perfusion, worsening ischemia, and an enlarging infarct zone. Three primary pathologic mechanisms exist for post-infarct MR: Papillary muscle rupture Acute ischemic MR Chronic ischemic MR. Post-infarct VSD follows large transmural infarction with weakening of the septal wall. Post-infarct VSD results in left-to-right shunt of variable magnitude with diversion of blood flow from systemic to pulmonary circulation and low-cardiac-output state, ultimately into cardiogenic shock. VFWR occurs after large, transmural MI in myocardium without collaterals. Traditionally ventricular aneurysm is defined as region of myocardium exhibiting abnormal diastolic contour with systolic dyskinesia and paradoxic bulging. Ventricular remodeling after large transmural infarct leads to infract expansion and aneurysm formation. Clinical features Symptoms of systemic and coronary hypoperfusion, including cold, clammy extremities, cyanosis, oliguria, and altered sensorium. Cardiogenic shock associated with MI leads to pulmonary edema, chest pain, and shortness of breath. New holosystolic murmur best heard at the apex is noted in MR associated with MI. Post-infarct VSD typically occurs 5 to 6 days after MI Eighty percent of VFWR occur within 7 days after infarct. Subacute VFWR results in a worsening pericardial effusion and hypotension without pulseless electrical activity and cardiac arrest. Pseudoaneurysm formation from VFWR occurs approximately 3 months after MI with variable symptomatology. Commonly presents with congestive heart failure LV aneurysm commonly presents with congestive heart failure, angina, and/or dyspnea. Mural thrombus present in 50 percent of ventricular aneurysm patients at surgery. Diagnostics Invasive hemodynamic monitoring important in optimizing both coronary and systemic perfusion. Electrocardiography (ECG) confirms cardiac ischemia; chest X-ray rules out pneumothorax. Emergent echocardiography (ECHO) to rule out other mechanical causes of shock, including papillary muscle or ventricular rupture. Echocardiography (ECHO) allows evaluation of left ventricular (LV) function and mitral apparatus; can accurately diagnose pulmonary muscle (PM) rupture as well as exclude other mechanical causes of cardiovascular collapse. Location of infarct of echocardiography (ECHO) correlates with location of post-infarct VSD. ECHO is important to differentiate post-infarct VSD from acute, severe mitral regurgitation (sensitivity and specificity ~100 percent). Angiography allows delineation of coronary anatomy, estimation of ventricular aneurysm size, and guided placement of intra-aortic balloon pump (IABP). Rapid pericardiocentesis is both diagnostic and therapeutic for VFWR. Echocardiography (ECHO) identifies effusion with pericardial clots for VFWR; Doppler evaluation may identify rupture site. MRI may be useful in ... Your Access profile is currently affiliated with '[InstitutionA]' and is in the process of switching affiliations to '[InstitutionB]'. Please click ‘Continue’ to continue the affiliation switch, otherwise click ‘Cancel’ to cancel signing in. Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Username Error: Please enter User Name Password Error: Please enter Password Forgot Username? Forgot Password? Sign in via OpenAthens Sign in via Shibboleth